LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.

Plasma low density lipoprotein (LDL) comprises multiple discrete subclasses differing in size, density, and chemical composition. A common, heritable phenotype characterized by the predominance of small, dense LDL particles (LDL subclass phenotype B) is associated with relatively increased concentrations of plasma triglycerides, reduced levels of high density lipoprotein, and increased risk of coronary artery disease in comparison with subjects with larger LDL (LDL subclass phenotype A). Population studies have indicated that approximately 20-30% of adult men have phenotype B, and another 15-20% have LDL of intermediate size. The lipid changes in phenotype B are similar to those that have been observed in patients with non-insulin-dependent diabetes mellitus (NIDDM). In the present study, we have assessed LDL subclass phenotypes in normolipidemic men with NIDDM and in age-matched control subjects who had similar lipid levels. There was a greater than twofold increase in the percentage of individuals with the LDL B phenotype in the NIDDM subjects. The LDL B phenotype was associated with higher plasma triglyceride levels and a trend toward lower high density lipoprotein cholesterol levels compared with the LDL A phenotype in the NIDDM subjects, as has been previously observed in control groups. Indices of diabetic control, such as fasting and hemoglobin A1 levels, were similar regardless of LDL phenotype pattern, suggesting that glycemic control was not likely to account for the increase in the LDL B phenotype. In both control and NIDDM subjects, the clearance of triglyceride-rich lipoproteins was slowed in the subjects with the LDL phenotype B compared with those with the A phenotype.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  B. Howard Lipoprotein metabolism in diabetes. , 1994, Current opinion in lipidology.

[2]  K. Feingold,et al.  Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. , 1992, The Journal of clinical endocrinology and metabolism.

[3]  R. Krauss,et al.  Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. , 1992, Atherosclerosis.

[4]  R. Krauss,et al.  Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Flier,et al.  Insulin resistance--mechanisms, syndromes, and implications. , 1991, The New England journal of medicine.

[6]  J. Hendriks,et al.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  Jack Wang,et al.  Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome , 1991 .

[8]  J. Wang,et al.  Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. , 1991, The American journal of medicine.

[9]  G. Bondjers,et al.  Effect of proteoglycans on lipoprotein-cell interactions: possible contribution to atherogenesis , 1990 .

[10]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[11]  G. Yoshino,et al.  Abnormal Lipoprotein Composition in Normolipidemic Diabetic Patients , 1990, Diabetes Care.

[12]  H. Barakat,et al.  Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. , 1990, Diabetes.

[13]  R. Krauss,et al.  Effects of exercise-induced weight loss on low density lipoprotein subfractions in healthy men. , 1989, Arteriosclerosis.

[14]  K. Hirschhorn Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. , 1989, American journal of human genetics.

[15]  K. Schechtman,et al.  Quantitative Relationship Between Plasma Lipids and Glycohemoglobin in Type I Patients: Longitudinal Study of 212 Patients , 1989, Diabetes Care.

[16]  S. Oikawa,et al.  Appearance of multidisperse low density lipoprotein and altered lipoprotein composition in non-insulin-dependent diabetes with type IIa hyperlipoproteinemia. , 1989, Metabolism: clinical and experimental.

[17]  H. Eder,et al.  Effect of diabetes on the metabolism of triacylglycerol-rich lipoproteins. , 1989, Biochemical Society transactions.

[18]  G. Gibbons Insulin, diabetes and hepatic very-low-density lipoprotein metabolism. , 1989, Biochemical Society transactions.

[19]  J. Wang,et al.  Hypertriglyceridemia in the acquired immunodeficiency syndrome. , 1989, The American journal of medicine.

[20]  M. King,et al.  Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. , 1988, American journal of human genetics.

[21]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[22]  B. Howard,et al.  Lipoprotein metabolism in diabetes mellitus. , 1987, Journal of lipid research.

[23]  R. Krauss,et al.  Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease. , 1987, American heart journal.

[24]  R. Krauss,et al.  GENETIC CONTROL OF LOW-DENSITY-LIPOPROTEIN SUBCLASSES , 1986, The Lancet.

[25]  B. Howard,et al.  Plasma and Lipoprotein Cholesterol and Triglyceride in the Pima Indian Population: Comparison of Diabetics and Nondiabetics , 1984, Arteriosclerosis.

[26]  S. Eisenberg,et al.  Plasma triglyceride determines structure-composition in low and high density lipoproteins. , 1984, Arteriosclerosis.

[27]  N. Ruderman,et al.  Diabetes as an atherogenic factor. , 1984, Progress in cardiovascular diseases.

[28]  J. Halter,et al.  The Response of Plasma Triglyceride, Cholesterol, and Lipoprotein Lipase to Treatment in Non-insulin-dependent Diabetic Subjects Without Familial Hypertriglyceridemia , 1983, Diabetes.

[29]  W. Fisher Heterogeneity of plasma low density lipoproteins manifestations of the physiologic phenomenon in man. , 1983, Metabolism: clinical and experimental.

[30]  C. Agardh,et al.  Improvement of the Plasma Lipoprotein Pattern After Institution of Insulin Treatment in Diabetes Mellitus , 1982, Diabetes Care.

[31]  J. Breslow,et al.  Hyperglycemia and Plasma Lipid Levels: Covariations in Insulin-dependent Diabetes , 1982, Diabetes Care.

[32]  R. Krauss,et al.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans. , 1982, Journal of lipid research.

[33]  G. Reaven,et al.  Diabetic Hypertriglyceridemia: Evidence for Three Clinical Syndromes , 1981, Diabetes.

[34]  A. Glasgow,et al.  Relationships Between Control and Serum Lipids in Juvenile-onset Diabetes , 1981, Diabetes Care.

[35]  J. Brunzell,et al.  Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity. , 1975, The Journal of clinical investigation.

[36]  D. Porte,et al.  Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes). , 1975, Metabolism: clinical and experimental.

[37]  G. Schonfeld,et al.  Apolipoprotein B Levels and Altered Lipoprotein Composition in Diabetes , 1974, Diabetes.

[38]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[39]  M. Hammond,et al.  Measurements of the molecular weight variability of plasma low density lipoproteins among normals and subjects with hyper- -lipoproteinemia. Demonstration of macromolecular heterogeneity. , 1972, Biochemistry.

[40]  J. Albers,et al.  Human serum lipoproteins. Evidence for three classes of lipoproteins in S fO-2. , 1972, Biochemistry.

[41]  V. Schumaker,et al.  Equilibrium banding of low-density lipoproteins. 3. Studies on normal individuals and the effects of diet and heparin-induced lipase. , 1970, Biochimica et biophysica acta.

[42]  D. M. Lee,et al.  Studies of the composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma. , 1970, Biochemistry.

[43]  G. Detakats DIABETIC VASCULAR DISEASE. , 1964, Southern medical journal.

[44]  J. Gofman,et al.  The ultracentrifugal characterization and isolation of human blood lipids and lipoproteins, with applications to the study of atherosclerosis. , 1951, The Journal of physical and colloid chemistry.